205 related articles for article (PubMed ID: 19485917)
1. Statins and ischaemia reperfusion injury: a molecular biological review.
Abdul Rahman MN; Chetter IC
Curr Vasc Pharmacol; 2010 Nov; 8(6):831-5. PubMed ID: 19485917
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
3. The effects of HMG-CoA reductase inhibitors on endothelial function.
Tesfamariam B
Am J Cardiovasc Drugs; 2006; 6(2):115-20. PubMed ID: 16555864
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
5. Direct vascular effects of HMG-CoA reductase inhibitors.
Laufs U; Liao JK
Trends Cardiovasc Med; 2000 May; 10(4):143-8. PubMed ID: 11239793
[TBL] [Abstract][Full Text] [Related]
6. The treatment of coronary heart disease: an update. Part 3: Statins beyond cholesterol lowering.
Kolovou G
Curr Med Res Opin; 2001; 17(1):34-7. PubMed ID: 11464443
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M
Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849
[TBL] [Abstract][Full Text] [Related]
8. Statins and ischemic stroke.
Liao JK
Atheroscler Suppl; 2002 May; 3(1):21-5. PubMed ID: 12044582
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic vascular protective effects of statins in perioperative medicine.
Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
[TBL] [Abstract][Full Text] [Related]
10. The effects of statins on endothelium, inflammation and cardioprotection.
Elrod JW; Lefer DJ
Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
[TBL] [Abstract][Full Text] [Related]
11. Influence of statin use on endothelial function: from bench to clinics.
Martínez-González J; Badimon L
Curr Pharm Des; 2007; 13(17):1771-86. PubMed ID: 17584107
[TBL] [Abstract][Full Text] [Related]
12. Are pleiotropic effects of statins real?
Corsini A; Ferri N; Cortellaro M
Vasc Health Risk Manag; 2007; 3(5):611-3. PubMed ID: 18078012
[TBL] [Abstract][Full Text] [Related]
13. Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor.
Jones SP; Gibson MF; Rimmer DM; Gibson TM; Sharp BR; Lefer DJ
J Am Coll Cardiol; 2002 Sep; 40(6):1172-8. PubMed ID: 12354446
[TBL] [Abstract][Full Text] [Related]
14. Pitavastatin: an overview.
Saito Y
Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
[TBL] [Abstract][Full Text] [Related]
15. Pitavastatin attenuates leukocyte-endothelial interactions induced by ischemia-reperfusion injury in the rat retina.
Miyaki K; Matsubara A; Nishiwaki A; Tomida K; Morita H; Yoshida M; Ogura Y
Curr Eye Res; 2009 Jan; 34(1):10-7. PubMed ID: 19172465
[TBL] [Abstract][Full Text] [Related]
16. Do statins lower blood pressure?
Mangat S; Agarwal S; Rosendorff C
J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):112-23. PubMed ID: 17562781
[TBL] [Abstract][Full Text] [Related]
17. Antioxidative effects of statins.
Adam O; Laufs U
Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
19. Statins and their role in vascular protection.
Mason JC
Clin Sci (Lond); 2003 Sep; 105(3):251-66. PubMed ID: 12793855
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy and angiogenesis.
Skaletz-Rorowski A; Walsh K
Curr Opin Lipidol; 2003 Dec; 14(6):599-603. PubMed ID: 14624137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]